Join the next generation of leading cancer scientists with fully-funded PhDs
Our competitive PhD programme is designed for science graduates who want a career in cancer research. We offer above-average stipends and exceptional facilities.
Applying for PhD projects
Funding and stipends
We provide a generous stipend and cover tuition fees for the majority of our PhD projects so you can focus on the research.
Current opportunities
Black Leaders in Cancer & Convergence PhD Studentships
We are currently inviting applications for two funded studentships offered through a joint recruitment call between the Black Leaders in Cancer Studentship and the Convergence PhD Programme.Just some of our PhD projects:
Early-Onset Breast Cancer Risk: Age-Specific Genetic Susceptibility and Prediction in Diverse Populations
Primary supervisor: Professor Montse Garcia-Closas Primary site: Sutton Funded by Marie Skłodowska-Curie Actions (MSCA) Doctoral NetworksModifiable Risk Factors and Cancer Burden in the UK: Trends, Impact, and Prevention Opportunities
Primary supervisor: Professor Montse Garcia-Closas Primary site: Sutton Funded by CRUK CD3 Programme
Student Profile
Timothy Sun Hon Mun is a PhD student in the Computational Imaging Team at the ICR. He is investigating the use of artificial intelligence (AI) and medical imaging in predicting survival outcomes and treatment response for patients with soft tissue sarcomas. His project is part of the Sarcoma Accelerator Consortium.
Student life
Our student committees and social life plus our day-to-day support and exceptional learning resources keep supporting you outside your research.
Support moving to the UK
We embrace researchers from across the world and you’ll get a variety of social, welfare and accommodation benefits & advice, to help your move to the UK.
Student Profile
Maria Coakley is a Clinical Research Fellow carrying out her PhD in the Division of Breast Cancer Research at the ICR. Her project involves working with patient samples collected from a clinical trial to investigate the evolution of triple-negative breast cancers.
.png?sfvrsn=c9f90a63_1){kind=logo}